QUALITY-OF-LIFE AS DEFINED BY ORTHOPEDIC ONCOLOGY PATIENTS

Citation
Jh. Healey et al., QUALITY-OF-LIFE AS DEFINED BY ORTHOPEDIC ONCOLOGY PATIENTS, Annals of surgical oncology, 4(7), 1997, pp. 591-596
Citations number
18
Categorie Soggetti
Surgery,Oncology
Journal title
ISSN journal
10689265
Volume
4
Issue
7
Year of publication
1997
Pages
591 - 596
Database
ISI
SICI code
1068-9265(1997)4:7<591:QADBOO>2.0.ZU;2-A
Abstract
Background: Quality of life (QOL), not just survival, is central to ou tcomes analysis in musculoskeletal oncology. However, little informati on exists about the patients' definition of what constitutes QOL. Meth ods: Self-administered outcomes questionnaires were given to 201 surgi cally treated patients with lower extremity tumors. Of these patients, 192 (137 with malignant tumors, 55 with benign tumors) provided a wri tten definition of QOL. Their responses were independently collated an d matched with clinical information. Results: For most patients (153, or 80%) the definition of QOL encompassed several attributes. A consis tent combination of four major attributes was used in the QOL definiti on by 44 (32%) of the malignant cases and 19 (35%) of the benign cases . Differences in responses between men and women were idiosyncratic an d more common in the benign group. Good family relations and good heal th were equally important to men and women. Responses varied by patien t age. Older patients valued self-sufficiency and freedom from pain, w hereas younger patients emphasized happiness, trust in God or church, achieving goals and being successful, and love. Those whose surgery wa s less extensive cited good family relations, the ability to function physically and emotionally, and having a good job or work. Conclusion: The variation in patients' perspectives and definitions of quality of life must be taken into account when assessing QOL in musculoskeletal oncology patients. Patients often emphasize concerns that are not ade quately addressed by current outcomes measures in orthopedics and gene ral oncology.